

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 9.38299447 |
| 2 | lymph vessel development (GO:0001945) | 8.69423596 |
| 3 | positive regulation of vasculogenesis (GO:2001214) | 8.54547830 |
| 4 | vascular endothelial growth factor signaling pathway (GO:0038084) | 7.55199201 |
| 5 | regulation of vasculogenesis (GO:2001212) | 7.10153600 |
| 6 | endothelial tube morphogenesis (GO:0061154) | 6.87161347 |
| 7 | morphogenesis of an endothelium (GO:0003159) | 6.87161347 |
| 8 | blood vessel maturation (GO:0001955) | 6.76158576 |
| 9 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 6.73037507 |
| 10 | surfactant homeostasis (GO:0043129) | 6.32271803 |
| 11 | lymphangiogenesis (GO:0001946) | 6.30934783 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.15819910 |
| 13 | regulation of endothelial cell differentiation (GO:0045601) | 5.53440651 |
| 14 | endothelial cell differentiation (GO:0045446) | 5.28021965 |
| 15 | aggressive behavior (GO:0002118) | 5.21818307 |
| 16 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.96695100 |
| 17 | basement membrane organization (GO:0071711) | 4.81731219 |
| 18 | hyperosmotic salinity response (GO:0042538) | 4.78279259 |
| 19 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.77058780 |
| 20 | chemical homeostasis within a tissue (GO:0048875) | 4.69083479 |
| 21 | sprouting angiogenesis (GO:0002040) | 4.66020017 |
| 22 | heart trabecula formation (GO:0060347) | 4.64371464 |
| 23 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.61107312 |
| 24 | protein kinase C signaling (GO:0070528) | 4.57972951 |
| 25 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.50007874 |
| 26 | glomerular filtration (GO:0003094) | 4.43211905 |
| 27 | venous blood vessel morphogenesis (GO:0048845) | 4.42801733 |
| 28 | ovulation from ovarian follicle (GO:0001542) | 4.28240068 |
| 29 | positive regulation of odontogenesis (GO:0042482) | 4.27498607 |
| 30 | regulation of female receptivity (GO:0045924) | 4.26090789 |
| 31 | female mating behavior (GO:0060180) | 4.24906257 |
| 32 | renal filtration (GO:0097205) | 4.23472973 |
| 33 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.19107833 |
| 34 | blood vessel endothelial cell migration (GO:0043534) | 4.15114236 |
| 35 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.14953865 |
| 36 | embryonic heart tube development (GO:0035050) | 4.04543702 |
| 37 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.03977859 |
| 38 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.96998614 |
| 39 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.96314021 |
| 40 | * vasculogenesis (GO:0001570) | 3.96029681 |
| 41 | angiogenesis involved in wound healing (GO:0060055) | 3.94581987 |
| 42 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.93015420 |
| 43 | ribosomal small subunit assembly (GO:0000028) | 3.91655520 |
| 44 | endothelial cell morphogenesis (GO:0001886) | 3.91116359 |
| 45 | patterning of blood vessels (GO:0001569) | 3.90301188 |
| 46 | Peyers patch development (GO:0048541) | 3.84484503 |
| 47 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.84484503 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.81594923 |
| 49 | cAMP biosynthetic process (GO:0006171) | 3.75580542 |
| 50 | mature B cell differentiation involved in immune response (GO:0002313) | 3.74649831 |
| 51 | viral transcription (GO:0019083) | 3.72606324 |
| 52 | grooming behavior (GO:0007625) | 3.69276093 |
| 53 | transcytosis (GO:0045056) | 3.67756623 |
| 54 | hyaluronan catabolic process (GO:0030214) | 3.67455080 |
| 55 | endothelial cell proliferation (GO:0001935) | 3.59669749 |
| 56 | negative regulation of vascular permeability (GO:0043116) | 3.59331922 |
| 57 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.56547557 |
| 58 | translational termination (GO:0006415) | 3.53633586 |
| 59 | endothelial cell chemotaxis (GO:0035767) | 3.49662622 |
| 60 | positive regulation of B cell differentiation (GO:0045579) | 3.44890573 |
| 61 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.44129269 |
| 62 | negative regulation of endothelial cell migration (GO:0010596) | 3.43378539 |
| 63 | negative regulation of cell size (GO:0045792) | 3.40296131 |
| 64 | positive regulation of urine volume (GO:0035810) | 3.36883168 |
| 65 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.35217272 |
| 66 | trabecula morphogenesis (GO:0061383) | 3.26928252 |
| 67 | protein maturation by protein folding (GO:0022417) | 3.26678257 |
| 68 | cell migration involved in heart development (GO:0060973) | 3.26476086 |
| 69 | autophagic vacuole fusion (GO:0000046) | 3.22979739 |
| 70 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.19358217 |
| 71 | heart trabecula morphogenesis (GO:0061384) | 3.19118929 |
| 72 | pinocytosis (GO:0006907) | 3.18138015 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.17665863 |
| 74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16287065 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16287065 |
| 76 | regulation of vascular permeability (GO:0043114) | 3.16186305 |
| 77 | translational elongation (GO:0006414) | 3.10741765 |
| 78 | drinking behavior (GO:0042756) | 3.10450216 |
| 79 | platelet dense granule organization (GO:0060155) | 3.06894419 |
| 80 | regulation of endothelial cell apoptotic process (GO:2000351) | 3.02375009 |
| 81 | positive regulation of protein kinase C signaling (GO:0090037) | 3.02033491 |
| 82 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.01315535 |
| 83 | negative regulation of platelet activation (GO:0010544) | 3.01210171 |
| 84 | UV protection (GO:0009650) | 2.99541922 |
| 85 | pentose-phosphate shunt (GO:0006098) | 2.99296662 |
| 86 | endothelial cell migration (GO:0043542) | 2.98316767 |
| 87 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.98291848 |
| 88 | thrombin receptor signaling pathway (GO:0070493) | 2.96785318 |
| 89 | cardiac myofibril assembly (GO:0055003) | 2.93359543 |
| 90 | blood vessel remodeling (GO:0001974) | 2.93035535 |
| 91 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.92074872 |
| 92 | positive regulation of cell junction assembly (GO:1901890) | 2.91823835 |
| 93 | positive regulation of focal adhesion assembly (GO:0051894) | 2.91823835 |
| 94 | establishment of endothelial barrier (GO:0061028) | 2.89660301 |
| 95 | response to thyroid hormone (GO:0097066) | 2.88928630 |
| 96 | sarcomere organization (GO:0045214) | 2.87926249 |
| 97 | tricarboxylic acid metabolic process (GO:0072350) | 2.87333020 |
| 98 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.86647972 |
| 99 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.85279864 |
| 100 | negative regulation of adherens junction organization (GO:1903392) | 2.83590196 |
| 101 | negative regulation of focal adhesion assembly (GO:0051895) | 2.83590196 |
| 102 | negative regulation of cell junction assembly (GO:1901889) | 2.83590196 |
| 103 | nucleotide salvage (GO:0043173) | 2.82996878 |
| 104 | cellular response to nitric oxide (GO:0071732) | 2.82864394 |
| 105 | regulation of urine volume (GO:0035809) | 2.81759722 |
| 106 | phagocytosis, recognition (GO:0006910) | 2.81541203 |
| 107 | regulation of endothelial cell migration (GO:0010594) | 2.81329773 |
| 108 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.80991373 |
| 109 | hyperosmotic response (GO:0006972) | 2.80774808 |
| 110 | substrate-dependent cell migration (GO:0006929) | 2.79105535 |
| 111 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.78895631 |
| 112 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.77921171 |
| 113 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.75550125 |
| 114 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.74976394 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 2.74818511 |
| 116 | nephron epithelium development (GO:0072009) | 2.74047310 |
| 117 | protein targeting to ER (GO:0045047) | 2.73125962 |
| 118 | prostaglandin biosynthetic process (GO:0001516) | 2.72889861 |
| 119 | prostanoid biosynthetic process (GO:0046457) | 2.72889861 |
| 120 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.72888338 |
| 121 | cotranslational protein targeting to membrane (GO:0006613) | 2.72383504 |
| 122 | valine metabolic process (GO:0006573) | 2.72334247 |
| 123 | purine nucleotide salvage (GO:0032261) | 2.71200171 |
| 124 | cellular hyperosmotic response (GO:0071474) | 2.70967742 |
| 125 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.70876680 |
| 126 | trabecula formation (GO:0060343) | 2.70578488 |
| 127 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.70398847 |
| 128 | viral life cycle (GO:0019058) | 2.70306321 |
| 129 | fatty acid transmembrane transport (GO:1902001) | 2.70238764 |
| 130 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.69419435 |
| 131 | pentose metabolic process (GO:0019321) | 2.68959559 |
| 132 | negative regulation of necrotic cell death (GO:0060547) | 2.67035691 |
| 133 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.66914306 |
| 134 | regulation of transmission of nerve impulse (GO:0051969) | 2.66797297 |
| 135 | negative regulation of B cell apoptotic process (GO:0002903) | 2.66287339 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.66069238 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.66069238 |
| 138 | coronary vasculature morphogenesis (GO:0060977) | 2.65585856 |
| 139 | positive regulation of endothelial cell migration (GO:0010595) | 2.65129926 |
| 140 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.64552820 |
| 141 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.62896258 |
| 142 | negative regulation of monooxygenase activity (GO:0032769) | 2.61236975 |
| 143 | negative regulation of epithelial cell migration (GO:0010633) | 2.60705185 |
| 144 | cell volume homeostasis (GO:0006884) | 2.60596682 |
| 145 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.60278607 |
| 146 | positive regulation of adherens junction organization (GO:1903393) | 2.58454597 |
| 147 | protein localization to endoplasmic reticulum (GO:0070972) | 2.57323553 |
| 148 | ribosomal small subunit biogenesis (GO:0042274) | 2.56774352 |
| 149 | negative regulation of cell fate specification (GO:0009996) | 2.56276507 |
| 150 | lung vasculature development (GO:0060426) | 2.55612764 |
| 151 | embryonic foregut morphogenesis (GO:0048617) | 2.54959104 |
| 152 | artery development (GO:0060840) | 2.54312194 |
| 153 | arginine catabolic process (GO:0006527) | 2.53413281 |
| 154 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.53411202 |
| 155 | glucose catabolic process (GO:0006007) | 2.52671121 |
| 156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50217344 |
| 157 | renal absorption (GO:0070293) | 2.44050823 |
| 158 | regulation of necrotic cell death (GO:0010939) | 2.43800786 |
| 159 | NADPH regeneration (GO:0006740) | 2.43012696 |
| 160 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41407643 |
| 161 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.40966366 |
| 162 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.40966366 |
| 163 | maternal behavior (GO:0042711) | 2.40578593 |
| 164 | deoxyribonucleotide catabolic process (GO:0009264) | 2.36931699 |
| 165 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.35484340 |
| 166 | anatomical structure maturation (GO:0071695) | 2.35051571 |
| 167 | neuron remodeling (GO:0016322) | 2.33496061 |
| 168 | negative regulation of granulocyte differentiation (GO:0030853) | 2.33328724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.54074961 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.32373952 |
| 3 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.43923843 |
| 4 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 3.03733104 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00953103 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.99513371 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.92522131 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.87777270 |
| 9 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.86655963 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.77676294 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56541109 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.45571869 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14390017 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.02486332 |
| 15 | P68_20966046_ChIP-Seq_HELA_Human | 1.96573879 |
| 16 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92755569 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87433229 |
| 18 | GATA1_19941826_ChIP-Seq_K562_Human | 1.79248675 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74919080 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.73092010 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72573620 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71952964 |
| 23 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69602548 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68897048 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68683271 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67674711 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.67287726 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.67287726 |
| 29 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.64176161 |
| 30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63395862 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62932361 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.62615030 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62181725 |
| 34 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61914104 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61908582 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60648404 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57581258 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57579217 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55018110 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54987775 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54890439 |
| 42 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53741781 |
| 43 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52818166 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.46369860 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43843009 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42601970 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42519734 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41236401 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38308141 |
| 50 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.37157751 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36600858 |
| 52 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.36569724 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33758782 |
| 54 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.29368051 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29181167 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.28066279 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27902988 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27599883 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26789367 |
| 60 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26439573 |
| 61 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26360329 |
| 62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25851083 |
| 63 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.25553653 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23924897 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23802018 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23504328 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23208643 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23130062 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23031488 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.22388638 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21637866 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21191886 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21177337 |
| 74 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20713442 |
| 75 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20704898 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.20688315 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20645739 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.20347289 |
| 79 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20150174 |
| 80 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19665096 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18814943 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18746187 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17345224 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16810696 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16274178 |
| 86 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16080613 |
| 87 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.16072850 |
| 88 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.15588434 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15316789 |
| 90 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15192393 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15106585 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14688466 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14615569 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14256076 |
| 95 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.14084927 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13869076 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13267543 |
| 98 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12490893 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11769107 |
| 100 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11525537 |
| 101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11375722 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10442756 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09776007 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09474830 |
| 105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09155956 |
| 106 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08338156 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 1.08007172 |
| 108 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07760818 |
| 109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07713266 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07420712 |
| 111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06175094 |
| 112 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06164425 |
| 113 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05945443 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05576829 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05167749 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05075197 |
| 117 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05057185 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04976239 |
| 119 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04921152 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03536255 |
| 121 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03369933 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03082166 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02861661 |
| 124 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.01909194 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01508388 |
| 126 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.01264951 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00046806 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99902967 |
| 129 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99701534 |
| 130 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99334772 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99131219 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99019913 |
| 133 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98177037 |
| 134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97992405 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97957801 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97751377 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97425375 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97156407 |
| 139 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97143475 |
| 140 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96365765 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95052173 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93438672 |
| 143 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93390432 |
| 144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91920590 |
| 145 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91867922 |
| 146 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91656909 |
| 147 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91533319 |
| 148 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91483373 |
| 149 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91050336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 7.24770802 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 6.20980399 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 5.71183233 |
| 4 | MP0004272_abnormal_basement_membrane | 3.57182049 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.52379615 |
| 6 | MP0003828_pulmonary_edema | 3.03353626 |
| 7 | MP0003724_increased_susceptibility_to | 2.80493507 |
| 8 | MP0006054_spinal_hemorrhage | 2.67136561 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.49306268 |
| 10 | MP0006138_congestive_heart_failure | 2.41818214 |
| 11 | MP0004147_increased_porphyrin_level | 2.38349197 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.21918625 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.21365486 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.06863977 |
| 15 | MP0000751_myopathy | 1.95344526 |
| 16 | MP0008775_abnormal_heart_ventricle | 1.94674176 |
| 17 | MP0005330_cardiomyopathy | 1.93566036 |
| 18 | MP0005385_cardiovascular_system_phenoty | 1.91981595 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 1.91981595 |
| 20 | MP0000767_abnormal_smooth_muscle | 1.86913765 |
| 21 | MP0003279_aneurysm | 1.84714818 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.80278326 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.78539197 |
| 24 | MP0009697_abnormal_copulation | 1.78412939 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.75466244 |
| 26 | MP0000343_altered_response_to | 1.70077444 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.64212227 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.63421351 |
| 29 | MP0005375_adipose_tissue_phenotype | 1.61632758 |
| 30 | MP0002127_abnormal_cardiovascular_syste | 1.60549509 |
| 31 | MP0003567_abnormal_fetal_cardiomyocyte | 1.60003644 |
| 32 | MP0000249_abnormal_blood_vessel | 1.59982945 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.56412063 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.55294879 |
| 35 | MP0005165_increased_susceptibility_to | 1.54360304 |
| 36 | MP0000749_muscle_degeneration | 1.54215109 |
| 37 | MP0004484_altered_response_of | 1.54038775 |
| 38 | MP0005451_abnormal_body_composition | 1.53628671 |
| 39 | MP0005670_abnormal_white_adipose | 1.50152861 |
| 40 | MP0001849_ear_inflammation | 1.45791088 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.45213930 |
| 42 | MP0005409_darkened_coat_color | 1.45040600 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.44891302 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.43142385 |
| 45 | MP0005595_abnormal_vascular_smooth | 1.41698279 |
| 46 | MP0002128_abnormal_blood_circulation | 1.41446389 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.40013722 |
| 48 | MP0004130_abnormal_muscle_cell | 1.38980530 |
| 49 | MP0009840_abnormal_foam_cell | 1.33709130 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.31770678 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.31643603 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.30137999 |
| 53 | MP0003075_altered_response_to | 1.20488162 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.19458989 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.19458989 |
| 56 | MP0009278_abnormal_bone_marrow | 1.19275944 |
| 57 | MP0003646_muscle_fatigue | 1.19009716 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.17013234 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.17003632 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.14739790 |
| 61 | * MP0002925_abnormal_cardiovascular_devel | 1.13744047 |
| 62 | MP0004087_abnormal_muscle_fiber | 1.13086074 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.12489676 |
| 64 | * MP0001614_abnormal_blood_vessel | 1.10546109 |
| 65 | MP0001958_emphysema | 1.07160618 |
| 66 | * MP0004085_abnormal_heartbeat | 1.06495473 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.06189279 |
| 68 | MP0000266_abnormal_heart_morphology | 1.05079442 |
| 69 | MP0008004_abnormal_stomach_pH | 1.03193629 |
| 70 | MP0000230_abnormal_systemic_arterial | 1.02785910 |
| 71 | MP0003943_abnormal_hepatobiliary_system | 1.02621521 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.97644737 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 0.94580571 |
| 74 | MP0002933_joint_inflammation | 0.94236027 |
| 75 | MP0002106_abnormal_muscle_physiology | 0.92745457 |
| 76 | MP0004883_abnormal_blood_vessel | 0.92250174 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 0.92165936 |
| 78 | MP0002132_abnormal_respiratory_system | 0.91761853 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.88638885 |
| 80 | MP0005535_abnormal_body_temperature | 0.88409423 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.88160087 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86942453 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.86557526 |
| 84 | MP0005164_abnormal_response_to | 0.83629724 |
| 85 | MP0004510_myositis | 0.81811357 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.81796358 |
| 87 | MP0005083_abnormal_biliary_tract | 0.81451755 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.81202845 |
| 89 | MP0001915_intracranial_hemorrhage | 0.80700870 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.78373120 |
| 91 | MP0003300_gastrointestinal_ulcer | 0.74870616 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 0.74569602 |
| 93 | MP0002971_abnormal_brown_adipose | 0.74377234 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73563942 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.72711989 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.71961356 |
| 97 | MP0003984_embryonic_growth_retardation | 0.70575267 |
| 98 | * MP0001784_abnormal_fluid_regulation | 0.69317431 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.69256881 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 0.68815044 |
| 101 | MP0010329_abnormal_lipoprotein_level | 0.68809122 |
| 102 | MP0005369_muscle_phenotype | 0.68733358 |
| 103 | MP0001661_extended_life_span | 0.68246072 |
| 104 | MP0005360_urolithiasis | 0.66752386 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.64975188 |
| 106 | MP0008995_early_reproductive_senescence | 0.64552239 |
| 107 | MP0001764_abnormal_homeostasis | 0.64025954 |
| 108 | MP0002269_muscular_atrophy | 0.63173393 |
| 109 | MP0001853_heart_inflammation | 0.62882941 |
| 110 | MP0003303_peritoneal_inflammation | 0.62590884 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.60981599 |
| 112 | MP0002398_abnormal_bone_marrow | 0.59493715 |
| 113 | MP0009931_abnormal_skin_appearance | 0.58299549 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.58149501 |
| 115 | MP0002429_abnormal_blood_cell | 0.58095709 |
| 116 | MP0001851_eye_inflammation | 0.58074784 |
| 117 | MP0000598_abnormal_liver_morphology | 0.57740798 |
| 118 | MP0000759_abnormal_skeletal_muscle | 0.57191057 |
| 119 | MP0003122_maternal_imprinting | 0.57132094 |
| 120 | MP0008260_abnormal_autophagy | 0.55951637 |
| 121 | MP0005334_abnormal_fat_pad | 0.55163525 |
| 122 | MP0005166_decreased_susceptibility_to | 0.53619698 |
| 123 | * MP0003948_abnormal_gas_homeostasis | 0.53380623 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.52893211 |
| 125 | MP0003186_abnormal_redox_activity | 0.52757947 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.52742345 |
| 127 | MP0000747_muscle_weakness | 0.52671890 |
| 128 | MP0005266_abnormal_metabolism | 0.52343914 |
| 129 | MP0004233_abnormal_muscle_weight | 0.52027066 |
| 130 | MP0002970_abnormal_white_adipose | 0.51895619 |
| 131 | MP0001175_abnormal_lung_morphology | 0.50882450 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.50779193 |
| 133 | MP0002133_abnormal_respiratory_system | 0.50150267 |
| 134 | MP0008874_decreased_physiological_sensi | 0.49998703 |
| 135 | MP0005501_abnormal_skin_physiology | 0.49740429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polycythemia (HP:0001901) | 7.20115261 |
| 2 | Spontaneous hematomas (HP:0007420) | 5.89322835 |
| 3 | Hematochezia (HP:0002573) | 5.13936215 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 4.90526021 |
| 5 | Esophageal varix (HP:0002040) | 4.16228555 |
| 6 | Ventricular tachycardia (HP:0004756) | 4.13311860 |
| 7 | Nonimmune hydrops fetalis (HP:0001790) | 4.12845461 |
| 8 | Cerebral hemorrhage (HP:0001342) | 4.05148645 |
| 9 | Sudden death (HP:0001699) | 4.01513814 |
| 10 | Lymphangioma (HP:0100764) | 3.83865161 |
| 11 | Conjunctival telangiectasia (HP:0000524) | 3.64963525 |
| 12 | Mesangial abnormality (HP:0001966) | 3.52086538 |
| 13 | Muscle fiber splitting (HP:0003555) | 3.49402093 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.45794431 |
| 15 | Visceral angiomatosis (HP:0100761) | 3.28817914 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.24089358 |
| 17 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.20788041 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 3.16296466 |
| 19 | Hemangiomatosis (HP:0007461) | 3.14101532 |
| 20 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.12804660 |
| 21 | Broad metatarsal (HP:0001783) | 3.12714637 |
| 22 | Atrial fibrillation (HP:0005110) | 3.11619114 |
| 23 | Lipoatrophy (HP:0100578) | 3.11512749 |
| 24 | Microcytic anemia (HP:0001935) | 3.07736868 |
| 25 | Increased connective tissue (HP:0009025) | 3.01980183 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 2.98896030 |
| 27 | Supraventricular tachycardia (HP:0004755) | 2.93968239 |
| 28 | Cerebral palsy (HP:0100021) | 2.93919105 |
| 29 | Hypoglycemic coma (HP:0001325) | 2.91667788 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 2.89679115 |
| 31 | Petechiae (HP:0000967) | 2.89315939 |
| 32 | Cavernous hemangioma (HP:0001048) | 2.87226848 |
| 33 | Hyperthyroidism (HP:0000836) | 2.86976028 |
| 34 | Menorrhagia (HP:0000132) | 2.86859714 |
| 35 | Acute lymphatic leukemia (HP:0006721) | 2.82365691 |
| 36 | Hypertensive crisis (HP:0100735) | 2.79762984 |
| 37 | Truncus arteriosus (HP:0001660) | 2.77686742 |
| 38 | Myoglobinuria (HP:0002913) | 2.76566302 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.69048797 |
| 40 | Dilated cardiomyopathy (HP:0001644) | 2.68363788 |
| 41 | Growth hormone excess (HP:0000845) | 2.67814192 |
| 42 | Polygenic inheritance (HP:0010982) | 2.66484916 |
| 43 | Portal hypertension (HP:0001409) | 2.65960549 |
| 44 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.63468224 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.58944981 |
| 46 | Distal lower limb amyotrophy (HP:0008944) | 2.58873579 |
| 47 | Palpitations (HP:0001962) | 2.56706194 |
| 48 | Myotonia (HP:0002486) | 2.56583632 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.55730391 |
| 50 | Abnormal number of erythroid precursors (HP:0012131) | 2.54673547 |
| 51 | Rhabdomyolysis (HP:0003201) | 2.52715535 |
| 52 | Joint stiffness (HP:0001387) | 2.50273852 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.49447614 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.48439553 |
| 55 | Mucosal telangiectasiae (HP:0100579) | 2.48363563 |
| 56 | Seborrheic dermatitis (HP:0001051) | 2.47353666 |
| 57 | Reticulocytosis (HP:0001923) | 2.47278625 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.44480478 |
| 59 | Hydroureter (HP:0000072) | 2.42755499 |
| 60 | Congenital, generalized hypertrichosis (HP:0004540) | 2.42659824 |
| 61 | Dysautonomia (HP:0002459) | 2.42280894 |
| 62 | Atrioventricular block (HP:0001678) | 2.41193076 |
| 63 | Thrombocytosis (HP:0001894) | 2.38954780 |
| 64 | Porencephaly (HP:0002132) | 2.37928628 |
| 65 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37302364 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.36153813 |
| 67 | Calf muscle hypertrophy (HP:0008981) | 2.35893296 |
| 68 | Hypertriglyceridemia (HP:0002155) | 2.35889844 |
| 69 | Aplastic anemia (HP:0001915) | 2.34684338 |
| 70 | Abnormality of the hepatic vasculature (HP:0006707) | 2.34628886 |
| 71 | Difficulty running (HP:0009046) | 2.34147008 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.33846384 |
| 73 | Adactyly (HP:0009776) | 2.33147386 |
| 74 | Hepatic necrosis (HP:0002605) | 2.30257270 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.29775785 |
| 76 | Cervical subluxation (HP:0003308) | 2.29435507 |
| 77 | Reticulocytopenia (HP:0001896) | 2.29246594 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.28978818 |
| 79 | Skull defect (HP:0001362) | 2.21680625 |
| 80 | Muscle stiffness (HP:0003552) | 2.20988372 |
| 81 | Impaired platelet aggregation (HP:0003540) | 2.20644233 |
| 82 | Abnormal platelet function (HP:0011869) | 2.20644233 |
| 83 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20363547 |
| 84 | Purpura (HP:0000979) | 2.19105192 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.17325126 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.16499734 |
| 87 | Venous abnormality (HP:0002624) | 2.16445342 |
| 88 | Subaortic stenosis (HP:0001682) | 2.15978619 |
| 89 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.15978619 |
| 90 | Gastrointestinal dysmotility (HP:0002579) | 2.15906454 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 2.13928151 |
| 92 | Abnormal pupillary function (HP:0007686) | 2.13595085 |
| 93 | Microvesicular hepatic steatosis (HP:0001414) | 2.13479333 |
| 94 | Trismus (HP:0000211) | 2.12816453 |
| 95 | Agammaglobulinemia (HP:0004432) | 2.12737745 |
| 96 | Cellulitis (HP:0100658) | 2.12463880 |
| 97 | Limb-girdle muscle atrophy (HP:0003797) | 2.11200914 |
| 98 | Capillary hemangiomas (HP:0005306) | 2.11189298 |
| 99 | Absent hand (HP:0004050) | 2.11062439 |
| 100 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10877974 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 2.10877974 |
| 102 | Delayed CNS myelination (HP:0002188) | 2.10380759 |
| 103 | Difficulty climbing stairs (HP:0003551) | 2.09309432 |
| 104 | Neonatal death (HP:0003811) | 2.08339067 |
| 105 | Pulmonary artery stenosis (HP:0004415) | 2.05849030 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.04178099 |
| 107 | Ileus (HP:0002595) | 2.02894434 |
| 108 | Mucopolysacchariduria (HP:0008155) | 2.02865358 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02865358 |
| 110 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.02859720 |
| 111 | Abnormality of the calf musculature (HP:0001430) | 2.02293626 |
| 112 | Abnormality of reticulocytes (HP:0004312) | 2.02225664 |
| 113 | Pulmonary hypertension (HP:0002092) | 2.01152231 |
| 114 | Hepatocellular necrosis (HP:0001404) | 2.00562144 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.99677455 |
| 116 | Facial diplegia (HP:0001349) | 1.98674737 |
| 117 | Large hands (HP:0001176) | 1.98348718 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98092328 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98092328 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98092328 |
| 121 | Severe visual impairment (HP:0001141) | 1.97541851 |
| 122 | Increased serum ferritin (HP:0003281) | 1.95071918 |
| 123 | Epistaxis (HP:0000421) | 1.94400323 |
| 124 | Achilles tendon contracture (HP:0001771) | 1.93834949 |
| 125 | Asymmetry of the thorax (HP:0001555) | 1.93409291 |
| 126 | Intestinal polyposis (HP:0200008) | 1.91976145 |
| 127 | Spinal rigidity (HP:0003306) | 1.91971388 |
| 128 | Intestinal polyp (HP:0005266) | 1.91905053 |
| 129 | Colitis (HP:0002583) | 1.91131263 |
| 130 | Thrombophlebitis (HP:0004418) | 1.91029892 |
| 131 | Testicular atrophy (HP:0000029) | 1.90978599 |
| 132 | Joint hemorrhage (HP:0005261) | 1.90914078 |
| 133 | Stroke (HP:0001297) | 1.90724568 |
| 134 | Panhypogammaglobulinemia (HP:0003139) | 1.90659575 |
| 135 | Protrusio acetabuli (HP:0003179) | 1.90353054 |
| 136 | Metaphyseal dysplasia (HP:0100255) | 1.90188685 |
| 137 | Increased muscle lipid content (HP:0009058) | 1.90041500 |
| 138 | Areflexia of lower limbs (HP:0002522) | 1.89494552 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89177614 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.89000164 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88601136 |
| 142 | Obstructive lung disease (HP:0006536) | 1.88601136 |
| 143 | Increased mean platelet volume (HP:0011877) | 1.87861750 |
| 144 | High pitched voice (HP:0001620) | 1.87666661 |
| 145 | Annular pancreas (HP:0001734) | 1.84969735 |
| 146 | Venous insufficiency (HP:0005293) | 1.84347892 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.83832473 |
| 148 | Progressive muscle weakness (HP:0003323) | 1.83108141 |
| 149 | Heart block (HP:0012722) | 1.81705359 |
| 150 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80258990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.93392498 |
| 2 | TGFBR2 | 3.74075108 |
| 3 | TGFBR1 | 3.41464769 |
| 4 | MAP2K3 | 2.16455225 |
| 5 | GRK1 | 2.10072840 |
| 6 | MYLK | 2.05427455 |
| 7 | TIE1 | 10.9913952 |
| 8 | BCKDK | 1.97161378 |
| 9 | PKN2 | 1.61089269 |
| 10 | ERN1 | 1.59576162 |
| 11 | PTK2B | 1.56217335 |
| 12 | NME2 | 1.52030865 |
| 13 | FLT3 | 1.51170933 |
| 14 | TTN | 1.35983041 |
| 15 | RIPK1 | 1.31999112 |
| 16 | PAK4 | 1.26761154 |
| 17 | MAP3K11 | 1.26591863 |
| 18 | TESK2 | 1.25915943 |
| 19 | PRKG2 | 1.20554942 |
| 20 | TEC | 1.19882291 |
| 21 | TRIB3 | 1.16885380 |
| 22 | SMG1 | 1.15911386 |
| 23 | PDK2 | 1.15551700 |
| 24 | KIT | 1.13526348 |
| 25 | LRRK2 | 1.07645735 |
| 26 | EPHB2 | 1.07532097 |
| 27 | ARAF | 1.04951422 |
| 28 | ABL2 | 1.03472009 |
| 29 | WEE1 | 1.02200184 |
| 30 | NTRK1 | 0.97988428 |
| 31 | BMX | 0.96842160 |
| 32 | TAOK3 | 0.94147322 |
| 33 | DAPK1 | 0.92678401 |
| 34 | MAP4K1 | 0.92241767 |
| 35 | MAPK12 | 0.92221012 |
| 36 | VRK2 | 0.90556406 |
| 37 | MAP3K13 | 0.90549773 |
| 38 | PTK6 | 0.90252031 |
| 39 | TESK1 | 0.89487738 |
| 40 | MAP3K3 | 0.87170046 |
| 41 | OBSCN | 0.86320018 |
| 42 | TNK2 | 0.80576362 |
| 43 | IRAK3 | 0.76434618 |
| 44 | FER | 0.75887471 |
| 45 | PRKD2 | 0.75744198 |
| 46 | ILK | 0.73943649 |
| 47 | PRKD3 | 0.73814664 |
| 48 | TBK1 | 0.73292536 |
| 49 | TAOK2 | 0.71715451 |
| 50 | GRK5 | 0.70791102 |
| 51 | PHKG2 | 0.70670514 |
| 52 | PHKG1 | 0.70670514 |
| 53 | MAPKAPK3 | 0.70085744 |
| 54 | MARK2 | 0.63066821 |
| 55 | PRKD1 | 0.62802933 |
| 56 | FGFR4 | 0.60759387 |
| 57 | RPS6KA2 | 0.60530374 |
| 58 | SCYL2 | 0.60002334 |
| 59 | PRKAA2 | 0.59945381 |
| 60 | DAPK2 | 0.59546699 |
| 61 | PBK | 0.58522776 |
| 62 | BUB1 | 0.56660339 |
| 63 | MAP2K2 | 0.55710603 |
| 64 | MUSK | 0.54499808 |
| 65 | ACVR1B | 0.53251512 |
| 66 | DMPK | 0.52960718 |
| 67 | SYK | 0.52532692 |
| 68 | ZAP70 | 0.52442412 |
| 69 | CSF1R | 0.48760812 |
| 70 | PRPF4B | 0.46122852 |
| 71 | BTK | 0.46073653 |
| 72 | ITK | 0.45700354 |
| 73 | MATK | 0.45108937 |
| 74 | HIPK2 | 0.45045837 |
| 75 | FES | 0.43658939 |
| 76 | LMTK2 | 0.43107505 |
| 77 | PDK3 | 0.42979174 |
| 78 | PDK4 | 0.42979174 |
| 79 | INSRR | 0.42638036 |
| 80 | HCK | 0.41584763 |
| 81 | AURKA | 0.41346497 |
| 82 | RAF1 | 0.41015141 |
| 83 | DYRK3 | 0.40589843 |
| 84 | PIM2 | 0.40447252 |
| 85 | DYRK1B | 0.40364455 |
| 86 | EPHB1 | 0.40011506 |
| 87 | TSSK6 | 0.39429004 |
| 88 | MAP3K1 | 0.38545191 |
| 89 | RPS6KA4 | 0.38436458 |
| 90 | CDK9 | 0.35833025 |
| 91 | AKT2 | 0.33983801 |
| 92 | JAK3 | 0.32277584 |
| 93 | PDGFRA | 0.32160333 |
| 94 | MAPK3 | 0.32028485 |
| 95 | MAP2K6 | 0.30936249 |
| 96 | LCK | 0.30815882 |
| 97 | PAK1 | 0.30039580 |
| 98 | CAMK1 | 0.29510214 |
| 99 | GRK6 | 0.28982007 |
| 100 | MAP3K7 | 0.28755021 |
| 101 | MTOR | 0.28397890 |
| 102 | NEK1 | 0.28145711 |
| 103 | MAPK4 | 0.27697669 |
| 104 | CDK8 | 0.27308722 |
| 105 | CDK7 | 0.27208526 |
| 106 | BRSK2 | 0.27086148 |
| 107 | TRPM7 | 0.27075715 |
| 108 | MAP3K6 | 0.26859204 |
| 109 | PIK3CG | 0.26745893 |
| 110 | IGF1R | 0.26495113 |
| 111 | PAK2 | 0.26411962 |
| 112 | NLK | 0.26194400 |
| 113 | ICK | 0.25936901 |
| 114 | MAPK7 | 0.25930845 |
| 115 | PDPK1 | 0.25533118 |
| 116 | NEK9 | 0.25504907 |
| 117 | RPS6KB2 | 0.25347581 |
| 118 | DAPK3 | 0.25152945 |
| 119 | CSK | 0.24971518 |
| 120 | STK10 | 0.24926851 |
| 121 | CAMK4 | 0.23949255 |
| 122 | MAPK10 | 0.23740253 |
| 123 | TYK2 | 0.23713532 |
| 124 | MAP3K8 | 0.23675318 |
| 125 | PTK2 | 0.23252741 |
| 126 | PKN1 | 0.23220470 |
| 127 | RPS6KL1 | 0.22895130 |
| 128 | RPS6KC1 | 0.22895130 |
| 129 | IKBKB | 0.22542009 |
| 130 | RPS6KA6 | 0.21669466 |
| 131 | MARK3 | 0.19991395 |
| 132 | MAP3K10 | 0.19667540 |
| 133 | CAMKK2 | 0.19560678 |
| 134 | SRC | 0.17386608 |
| 135 | MAPK15 | 0.15132775 |
| 136 | EGFR | 0.14073358 |
| 137 | GSK3A | 0.13612777 |
| 138 | EEF2K | 0.13578279 |
| 139 | VRK1 | 0.13467024 |
| 140 | MAP2K1 | 0.13268032 |
| 141 | MAP3K12 | 0.13151652 |
| 142 | CCNB1 | 0.12782227 |
| 143 | SIK1 | 0.12578784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.80546526 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.94486933 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.93777066 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.88568817 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.87750191 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.81055074 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.75311651 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52008377 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30023625 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.24106864 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.02566163 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.97292858 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82647704 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.82110783 |
| 15 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.74798111 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71437035 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.67443777 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.67020498 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.66258561 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64230674 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.63980640 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61211267 |
| 23 | Platelet activation_Homo sapiens_hsa04611 | 1.56936687 |
| 24 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.56254194 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51212329 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.50485406 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.49845779 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42480078 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37733500 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34140283 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32751651 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.24878978 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24555637 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23835845 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22765052 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19407370 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.18808162 |
| 38 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.17957527 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16020926 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.14984788 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11920146 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11143255 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.10844253 |
| 44 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.10391700 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.09337608 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08799181 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.08379289 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07634665 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06374164 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05063271 |
| 51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04794584 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03793396 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03590657 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01867119 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.99991735 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99977691 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99914124 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.99101764 |
| 59 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.95850711 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94636632 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.93045265 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91894473 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90300981 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.90188546 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.90062244 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90027789 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88277417 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88131369 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87924920 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.87494087 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85461413 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.82890393 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82732954 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.82255850 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80825071 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80220441 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77582105 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.77491036 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76613388 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76101077 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75344402 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75278546 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74418023 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73134870 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70517146 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69601225 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.68758356 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.66374555 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66364617 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64656493 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.64226905 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60234110 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59621873 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58877842 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58257768 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57883279 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57457483 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54925336 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53259634 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52303678 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51986102 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51368711 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50613702 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.50557140 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49453786 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.48946581 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48468440 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47667965 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47559903 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46901504 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46572019 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46283580 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45895521 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.44432741 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44229726 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42451301 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.42065841 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42005799 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.41662077 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41441504 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41426684 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41157085 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41035612 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40827321 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40659017 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.40024679 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39567020 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.38671398 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38029305 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37941228 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37132880 |
| 132 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37122756 |
| 133 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37098378 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36455848 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35825630 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35187664 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35024213 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32829011 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30857243 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30610884 |

